View Older Stories View More Recent Stories

Jan 19, 2021 09:15AM Rayonier Announces the Election of Meridee A. Moore and Matthew J. Rivers to its Board of Directors
Jan 19, 2021 08:00AM Imago BioSciences Appoints Matthew J. Plunkett as Chief Financial Officer
Jan 19, 2021 06:34AM Beam Therapeutics Inc. (BEAM) Announces $260 Million Common Stock Investment from Multiple Investors
Jan 19, 2021 06:30AM Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
Jan 19, 2021 06:30AM Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
Jan 15, 2021 01:19PM Form SC 13D/A Playa Hotels & Resorts Filed by: FARALLON CAPITAL MANAGEMENT LLC
Jan 15, 2021 01:17PM Form SC 13G/A Generation Bio Co. Filed by: FARALLON CAPITAL MANAGEMENT LLC
Jan 14, 2021 08:01AM Tiga Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing January 14, 2021
Jan 12, 2021 08:00AM Imago BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 5, 2021 07:00AM Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds
Jan 4, 2021 08:07AM Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing
Dec 24, 2020 08:27PM U.S. hedge fund Farallon joins top Toshiba shareholder in call for EGM
Dec 24, 2020 08:00PM Farallon requests Toshiba Corporation Convene an EGM to Explain and Seek Shareholder Approval Regarding Significant Changes to the Toshiba Next Plan Relating to a New One Trillion Yen Growth Investing
Dec 22, 2020 08:00AM SomaLogic Adds $81M to Series A Financing Totaling $214M
Dec 22, 2020 08:00AM SomaLogic Adds $81M to Series A Financing Totaling $214M
Dec 5, 2020 07:30AM Imago BioSciences’ Bomedemstat (IMG-7289) Shows Sustained Clinical Activity in Phase 2 Interim Data for Treatment of Myelofibrosis
Nov 30, 2020 08:00AM Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong
Nov 27, 2020 11:35AM Tiga Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Units
Nov 25, 2020 12:57PM SomaLogic Closes $121M Series A Financing Led by Casdin Capital
Nov 25, 2020 12:57PM SomaLogic Closes $121M Series A Financing Led by Casdin Capital
Nov 24, 2020 04:02PM Form SC 13D/A Playa Hotels & Resorts Filed by: FARALLON CAPITAL MANAGEMENT LLC
Nov 24, 2020 10:27AM IPO for SPAC Tiga Acquisition (TINV) Opens Modestly Higher
Nov 23, 2020 09:52PM Tiga Acquisition Corp. Announces Pricing of $240,000,000 Initial Public Offering
Nov 23, 2020 08:00AM Imago BioSciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
Nov 19, 2020 09:26AM Pre-Open Stock Movers 11/19: (FENT) (APVO) (SONO) Higher; (MGTX) (GPRO) (CUB) Lower (more...)
Nov 19, 2020 08:00AM Imago BioSciences Raises $80 Million in Series C Financing
Nov 19, 2020 06:30AM Playa Hotels & Resorts (PLYA) Prices 13.576M Share Upsized Secondary Offering at $4.10/Sh
Nov 18, 2020 10:05PM Playa Hotels & Resorts N.V. Announces Pricing of Upsized Secondary Offering of 13,575,739 Ordinary Shares by Selling Shareholders
Nov 18, 2020 10:05PM Playa Hotels & Resorts N.V. Announces Pricing of Upsized Secondary Offering of 13,575,739 Ordinary Shares by Selling Shareholders
Nov 16, 2020 04:02PM Playa Hotels & Resorts (PLYA) Announces Secondary Offering of 12.5M Ordinary Shares by Selling Shareholders
Nov 16, 2020 04:01PM Playa Hotels & Resorts N.V. Announces Secondary Offering of 12,500,000 Ordinary Shares by Selling Shareholders
Nov 16, 2020 04:01PM Playa Hotels & Resorts N.V. Announces Secondary Offering of 12,500,000 Ordinary Shares by Selling Shareholders
Nov 16, 2020 09:22AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Nov 16, 2020 09:22AM Form 13F-NT Farallon Capital Europe For: Sep 30
Nov 16, 2020 09:22AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
Nov 16, 2020 09:22AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Oct 28, 2020 08:30AM Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company
Oct 27, 2020 04:05PM Digimarc Welcomes Noted Venture Capitalist and Advisor Alicia Syrett to its Board of Directors
Aug 26, 2020 07:00AM Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Aug 20, 2020 05:27PM Form SC 13G AMYRIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
Aug 14, 2020 05:13PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2020 02:35PM Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2020 02:35PM Form 13F-NT Farallon Capital Europe For: Jun 30
Aug 4, 2020 09:58AM TOCA Football To Open The World's First Soccer Entertainment Venue In London
Jul 30, 2020 01:25AM AUTO1 raises $300 million to develop used-car retail platform
Jul 27, 2020 09:37PM Argentina: Letter of Support of Joint Debt Restructuring Proposal
Jul 22, 2020 09:20AM U.S. hedge fund Farallon to vote for activist-backed Toshiba board nominees
Jul 22, 2020 09:19AM Farallon plans to vote for the shareholder proposals at Toshiba's 181st Annual General Meeting
Jul 22, 2020 08:00AM Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for Debilitating Neurologic
Jul 16, 2020 04:58PM Proxy advisers ISS, Glass Lewis back Toshiba, recommend against dissidents
View More Recent Stories View Older Stories